-
Amsterdam Dementia Cohort - Demographics & Neurological/Physical Examination
Data collection of the Amsterdam Dementia Cohort started in 2010 and is ongoing. All study participants undergo a standardized screening protocol for dementia. This dataset... -
Amsterdam Dementia Cohort - Neuroimaging & Neurophysiology
Data collection of the Amsterdam Dementia Cohort started in 2010 and is ongoing. All study participants undergo a standardized screening protocol for dementia. This dataset... -
test title
test description -
COMODULATE Lab results LUMC
COMODULATE Lab results LUMC Research laboratory data of the LUMC COMODULATE cohort. Retrospective observational non-WMO study including COVID-19 and Influenza patients with and... -
BEAT COVID Severity Score LUMC
BEAT COVID Severity Score LUMC Research laboratory data of LUMC BEAT COVID cohort. Prospective observational WMO study including 191 COVID-19 patients from April 2020 to March... -
BEAT COVID Lab results LUMC
BEAT COVID Lab results LUMC Research laboratory data of LUMC BEAT COVID cohort. Prospective observational WMO study including 191 COVID-19 patients from April 2020 to March... -
BEAT COVID Viral Ct
BEAT COVID Viral Ct Research laboratory data of LUMC BEAT COVID cohort. Prospective observational WMO study including 191 COVID-19 patients from April 2020 to March 2021. Over... -
BEAT COVID Info LUMC
BEAT COVID Info LUMC Research laboratory data of LUMC BEAT COVID cohort. Prospective observational WMO study including 191 COVID-19 patients from April 2020 to March 2021. Over... -
test
tasdasd -
Substudy UCC-SMART Oracle
SMART-ORACLE aims to determine the additional value of contrast-enhanced CT of the coronary and carotid arteries on top of traditional cardiovascular risk factors in patients... -
UCC-SMART
The UCC-SMART Study is a single-centre prospective cohort study, ongoing in both inclusion (600 new patients included per year) and follow-up, in which patient care and... -
Substudy UCC-SMART 2
Patients with a history of CVD or diabetes are invited to participate in the SMART-2 substudy. In this study, the baseline measurements of UCC-SMART are repeated in order to... -
COVID-19 GWAS and Allele Frequency Lookup Dataset with Population 12...
This dataset is being used as part of the GDI Milestone 8, containing VCFs and phenotypic data in CSV format about 41514 samples. The dataset consists only of synthetic data. -
Questionnaire data of the Personalised RISk-based MAmmascreening Study (PRISMA)
The primary aim of the PRISMA study was to investigate the potential value of risk-tailored versus traditional breast cancer screening protocols in the Netherlands. Data... -
Questionnaire data of the Personalised RISk-based MAmmascreening Study (PRISMA)
The primary aim of the PRISMA study was to investigate the potential value of risk-tailored versus traditional breast cancer screening protocols in the Netherlands. Data... -
Questionnaire data of the Personalised RISk-based MAmmascreening Study (PRISMA)
The primary aim of the PRISMA study was to investigate the potential value of risk-tailored versus traditional breast cancer screening protocols in the Netherlands. Data... -
Questionnaire data of the Personalised RISk-based MAmmascreening Study (PRISMA)
The primary aim of the PRISMA study was to investigate the potential value of risk-tailored versus traditional breast cancer screening protocols in the Netherlands. Data... -
Questionnaire data of the Personalised RISk-based MAmmascreening Study (PRISMA)
The primary aim of the PRISMA study was to investigate the potential value of risk-tailored versus traditional breast cancer screening protocols in the Netherlands. Data... -
Questionnaire data of the Personalised RISk-based MAmmascreening Study (PRISMA)
The primary aim of the PRISMA study was to investigate the potential value of risk-tailored versus traditional breast cancer screening protocols in the Netherlands. Data... -
Questionnaire data of the Personalised RISk-based MAmmascreening Study (PRISMA)
The primary aim of the PRISMA study was to investigate the potential value of risk-tailored versus traditional breast cancer screening protocols in the Netherlands. Data...